Professor Wang completed her PhD in biomedical engineering at the University of Toronto, where she developed engineered tissues and organ-on-a-chip systems for disease modelling and preclinical drug testing. She pursued her postdoctoral training at the Massachusetts Institute of Technology as a Banting Postdoctoral Fellow, working on micro- and nanoengineered drug-delivery systems for tissue regeneration, vaccines and precision therapeutics.
Wang’s laboratory works at the interface of biomaterials, micro- and nanoengineering, tissue engineering and smart devices to develop programmable therapeutic systems, microengineered living tissues and intelligent microdevices. The overarching goal of her research is to engineer precision biointerfaces across scales to better model disease, control therapeutic delivery and advance translational technologies for regenerative medicine and human health.s.